Clanfenur( —— )

Catalog No. M20195 CAS No. 51213-99-1

Clanfenur belongs to a new group of substituted benzoylphenylureas. The drug shows both in vitro and in vivo antitumour activity.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	91	In Stock
5MG	131	In Stock
10MG	186	In Stock
25MG	336	In Stock
50MG	480	In Stock
100MG	687	In Stock
500MG	1431	In Stock
1G	Get Quote	In Stock

Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Clanfenur
Note

Research use only, not for human use.
Brief Description

Clanfenur belongs to a new group of substituted benzoylphenylureas. The drug shows both in vitro and in vivo antitumour activity.
Description

Clanfenur belongs to a new group of substituted benzoylphenylureas. The drug shows both in vitro and in vivo antitumour activity.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Others
Target

Other Targets
Recptor

Others
Research Area

——
Indication

——

Chemical Information

CAS Number

51213-99-1
Formula Weight

335.76
Molecular Formula

C16H15ClFN3O2
Purity

>98% (HPLC)
Solubility

DMSO:soluble
SMILES

CN(C)c1cccc(F)c1C(=O)NC(=O)Nc1ccc(Cl)cc1
Chemical Name

N-((4-chlorophenyl)carbamoyl)-2-(dimethylamino)-6-fluorobenzamide

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1.Jonkman-de Vries J D Bj V D B ten Bokkel-Huinink W W et al. Pharmaceutical development of a parenteral formulation of the investigational anticancer drug clanfenur[J]. Pda J Pharm Sci Technol 1997 51(2):89-95.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

Product			Quantity Required*
Name *			E-mail Address *
Organization *			Phone Number
Remarks